Schedule 13D ownership disclosure
Cardiff Oncology Inc
Security class unavailable · CUSIP: 14147L108
Event date: 2022-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-000734
- Form type
- SC 13D
- Filer
- ACORN BIOVENTURES, L.P.
- CIK
- CIK 1766853
- Filed
- Jan 26, 2023
- Reporting period
- Sep 13, 2022
- Description
- Schedule 13D beneficial ownership